SCHEMBL9762592

SCHEMBL9762592

CCC(CC)CCCc1sc([N+](=O)[O-])nc1NC1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.42
MEN1 O00255 8/20 0.42
GABBR2 O75899 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
GABBR1 Q9UBS5 1/20 0.39
NPC1 O15118 1/20 0.36
MITF O75030 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 3/20 0.35
BLM P54132 2/20 0.35
GSK3A P49840 1/20 0.35
GSK3B P49841 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
CDK2 P24941 1/20 0.34
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9762473 0.79 KMT2A (0.44) KMT2AMEN1GABBR2CYP1A2CYP2C9
SCHEMBL9761511 0.76 KMT2A (0.36) KMT2AMEN1GABBR2CYP1A2CYP2C9
SCHEMBL9762643 0.74
SCHEMBL9761203 0.73
SCHEMBL9761277 0.68 CYP1A2 (0.37) KMT2AMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL9762597 0.65 KMT2A (0.40) KMT2AMEN1GABBR2CYP1A2CYP2C9
SCHEMBL9762606 0.65 KMT2A (0.42) KMT2AMEN1GABBR2CYP1A2CYP2C9
SCHEMBL9762128 0.63 KMT2A (0.44) KMT2AMEN1GABBR2CYP1A2CYP2C9
SCHEMBL10400088 0.62 FDPS (0.34) MAPTLMNA
SCHEMBL9762323 0.62 NPC1 (0.49) KMT2AMEN1GABBR2CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026694-A Antitumor agents THE BRITISH COLUMBIA CANCER FOUNDATION (CA) 1991-06-25 US disclosed